Insulin Pumps Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product, Type, Accessories), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Insulin Pumps Market size stood at USD 7.8 billion in 2026 and is predicted to grow at a 7.41% CAGR from 2027 to 2036, exceeding USD 15.94 billion by 2036. The industry revenue for 2027 is calculated at USD 8.29 billion.
Get more details on this report
Request Free Sample ReportInsulin Pumps Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 48.26% share, driven by advanced diabetes care adoption, strong reimbursement systems, CGM integration, and clinician familiarity with intensive insulin delivery technologies.
- Asia Pacific is growing at 9.38% CAGR due to rising diabetes prevalence, improving diagnosis rates, expanding urban healthcare access, and increasing adoption of modern insulin delivery devices.
Segment Momentum
- Hospitals accounted for 47.06% of the market in 2026 due to their central role in pump initiation, dose adjustment, specialist supervision, and management of complex insulin-dependent cases.
- Disposable Pumps are the fastest-growing product segment because they offer a more convenient and less burdensome insulin delivery format, appealing to users seeking simpler day-to-day diabetes management.
Market Expansion Drivers
- Rising diabetes and obesity prevalence accelerating adoption of advanced insulin delivery technologies.
- Integration of continuous glucose monitoring and automated insulin delivery improving diabetes management outcomes.
- Growing demand for connected and tubeless insulin pumps enhancing patient convenience and remote monitoring capabilities.
Leading Market Participants
- Leading players in the insulin pumps market include Medtronic plc (Ireland), Insulet Corporation (United States), Tandem Diabetes Care, Inc. (United States), Roche Holding AG (Switzerland), Ypsomed AG (Switzerland), Sanofi S.A. (France), SOOIL Development Co., Ltd. (South Korea), Cellnovo Group S.A. (France), Valeritas Holdings, Inc. (United States), Jiangsu Delfu Medical Device Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.8 billion
- 2027 Estimated Market Size: USD 8.29 billion.
- Projected Market Size: USD 15.94 billion by 2036
- Growth Forecast: 7.41% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Tethered Pumps (Product) | Traditional Insulin Pumps (Type) | Infusion Sets (Accessories)
- Emerging Opportunity Segment: Homecare Settings (End-use) | Disposable Pumps (Product) | Patch Pumps (Type) | Reservoirs (Accessories)
Market Growth Drivers and Industry Trends
Rising diabetes and obesity prevalence accelerating adoption of advanced insulin delivery technologies
Increasing prevalence of diabetes and obesity is expanding the number of patients requiring effective long-term glucose and insulin management, which will drive the insulin pumps market growth. Insulin pumps provide continuous delivery of insulin and can offer greater flexibility in managing changing insulin requirements compared with multiple manual injections. As patients and healthcare providers seek treatment approaches that support more consistent insulin administration and individualized diabetes management, advanced pump-based delivery systems are gaining greater relevance.
Integration of continuous glucose monitoring and automated insulin delivery improving diabetes management outcomes
Combining insulin pumps with continuous glucose monitoring is enabling more responsive diabetes management by linking glucose information with insulin delivery decisions, thereby propelling insulin pumps market growth. Integrated systems can continuously track glucose levels and, where automated functionality is available, adjust insulin delivery according to detected changes. This connectivity reduces reliance on isolated monitoring and manual intervention while providing patients and clinicians with more comprehensive information for managing glucose levels and treatment patterns.
Growing demand for connected and tubeless insulin pumps enhancing patient convenience and remote monitoring capabilities
Patient preference for less restrictive and more digitally connected treatment options is increasing interest in tubeless and connected pump technologies, supporting insulin pumps market growth. Tubeless designs can reduce the inconvenience associated with conventional tubing and provide greater flexibility during daily activities, while connected systems can transmit treatment and device information for remote monitoring. These capabilities can facilitate ongoing communication between patients and healthcare providers while giving users greater freedom in managing insulin delivery during everyday routines.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising diabetes and obesity prevalence accelerating adoption of advanced insulin delivery technologies | 2.20% | Moderate | North America, Asia Pacific | High | Near Term |
| Integration of continuous glucose monitoring and automated insulin delivery improving diabetes management outcomes | 2.00% | High | North America, Europe | High | Mid Term |
| Growing demand for connected and tubeless insulin pumps enhancing patient convenience and remote monitoring capabilities | 1.70% | Moderate | Asia Pacific, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The North America insulin pumps market held the largest share of 48.26% in 2026, supported by advanced diabetes care infrastructure, strong adoption of automated and connected medical devices, and increasing preference for technologies that enable continuous and personalized insulin delivery. Insulin pumps can provide greater flexibility in diabetes management compared with conventional administration approaches, supporting demand among patients and healthcare providers seeking more integrated treatment options. The region's established medical technology ecosystem and emphasis on digital health are also facilitating the integration of pumps with monitoring and data-management technologies. Continued innovation in device functionality and growing interest in personalized disease management are reinforcing regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region in the insulin pumps market, benefiting from expanding healthcare infrastructure, increasing diabetes awareness, and improving access to advanced treatment technologies. Greater recognition of the benefits of intensive and personalized diabetes management is encouraging interest in insulin pump therapy, while improvements in specialist healthcare services are supporting wider adoption. The expansion of healthcare facilities and increasing availability of medical technologies are helping reduce barriers to advanced diabetes treatment. Moreover, growing interest in connected healthcare and digitally enabled disease management is creating additional opportunities for insulin pumps, supporting the region's rapid market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Technology AdoptionGermany focuses on insulin pump technologies that improve dosing precision and support evidence-based diabetes care. German healthcare providers increasingly adopt advanced pump systems with enhanced safety features and interoperability across diabetes management platforms.
France 🇫🇷
Personalized Diabetes CareFrance promotes insulin pump use as part of individualized diabetes management strategies that support better treatment outcomes. French healthcare providers increasingly encourage advanced pump technologies that improve patient convenience and consistent insulin administration.
Italy 🇮🇹
Outpatient Therapy SupportItaly emphasizes insulin pumps that enable effective diabetes management beyond hospital settings through reliable wearable technologies. Italian healthcare providers increasingly encourage practical pump solutions that simplify long-term therapy while supporting patient independence.
Japan 🇯🇵
Compact Device PreferenceJapan values compact, reliable insulin pumps that fit everyday lifestyles while maintaining precise insulin delivery. Japanese manufacturers continue refining wearable technologies that improve comfort, usability, and long-term patient acceptance.
South Korea 🇰🇷
Connected Care EcosystemSouth Korea advances insulin pump adoption through digitally connected diabetes management solutions and expanding healthcare technology infrastructure. South Korean providers increasingly emphasize integrated monitoring capabilities that strengthen patient engagement and treatment efficiency.
United States 🇺🇸
Digital Diabetes ManagementThe U.S. insulin pumps market increasingly integrates connected technologies with continuous glucose monitoring to improve diabetes management. U.S. healthcare providers prioritize user-friendly systems that support personalized insulin delivery and better long-term treatment adherence.
Segment Leadership and Growth Trends
Insulin Pumps Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)
In the insulin pumps market, hospitals accounted for the largest share of 47.06% in 2026, supported by their importance in initiating insulin pump therapy, evaluating patients, and providing clinical supervision. Hospital-based care offers access to endocrinology expertise, diabetes management resources, and the monitoring capabilities required to establish appropriate pump use. Healthcare professionals can also provide education and device guidance, helping patients transition effectively to insulin pump-based treatment.
Homecare settings are advancing at the fastest pace as diabetes management increasingly emphasizes convenience, patient independence, and continuous therapy outside traditional healthcare facilities. Insulin pumps enable patients to manage insulin delivery within their daily routines while reducing the need for frequent facility-based administration. Growing preference for personalized and flexible diabetes care is therefore supporting the wider adoption of pump-based therapy in home environments.
Product Segment Analysis: Tethered Pumps (Largest Segment) vs Disposable Pumps (Fastest-Growing Segment)
Tethered pumps represented the largest share of the insulin pumps market in 2026, reflecting their established role in providing continuous and controlled insulin delivery. These systems connect the pump to the patient through an infusion set, enabling consistent administration while allowing users to adjust delivery according to their treatment requirements. Their established clinical use, familiarity among healthcare professionals, and ability to support intensive insulin management continue to sustain demand for tethered pump systems.
Disposable pumps are expected to grow at the fastest rate as patients and healthcare providers seek simpler insulin delivery options with reduced device-management requirements. Disposable designs can offer greater convenience by limiting maintenance and simplifying device replacement, which may improve usability for patients seeking less complex treatment routines. Increasing interest in patient-centric diabetes management and portable delivery technologies is creating additional opportunities for disposable insulin pump adoption.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Homecare Settings, Others | Hospitals | Homecare Settings |
| Product | Tethered Pumps, Disposable Pumps | Tethered Pumps | Disposable Pumps |
| Type | Traditional Insulin Pumps, Patch Pumps | Traditional Insulin Pumps | Patch Pumps |
| Accessories | Reservoirs, Infusion Sets, Batteries, Others | Infusion Sets | Reservoirs |
Competitive Landscape and Market Positioning
Key companies in the insulin pumps market:
1. Medtronic plc (Ireland)
2. Insulet Corporation (United States)
3. Tandem Diabetes Care Inc. (United States)
4. Roche Holding AG (Switzerland)
5. Ypsomed AG (Switzerland)
6. Sanofi S.A. (France)
7. SOOIL Development Co. Ltd. (South Korea)
8. Cellnovo Group S.A. (France)
9. Valeritas Holdings Inc. (United States)
10. Jiangsu Delfu Medical Device Co. Ltd. (China)
The insulin pumps market is witnessing significant transformation through the integration of continuous glucose monitoring systems and automated insulin delivery technologies. Manufacturers are emphasizing compact designs, real-time monitoring, and smartphone connectivity to improve diabetes management efficiency. Increasing awareness regarding personalized healthcare solutions is further encouraging adoption of advanced insulin pump systems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Insulet Corporation (United States) | |||||||
| Tandem Diabetes Care Inc. (United States) | |||||||
| Roche Holding AG (Switzerland) | |||||||
| Ypsomed AG (Switzerland) | |||||||
| Sanofi S.A. (France) | |||||||
| SOOIL Development Co. Ltd. (South Korea) | |||||||
| Cellnovo Group S.A. (France) | |||||||
| Valeritas Holdings Inc. (United States) | |||||||
| Jiangsu Delfu Medical Device Co. Ltd. (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| ViCentra | May-26 | ViCentra initiated commercial-scale manufacturing of its Kaleido insulin pump technology via its partnership with Phillips Medisize. The initiative triples production capacity to support large-scale supply readiness for over 17,000 European users, significantly strengthening the company's ability to scale automated insulin delivery infrastructure. |
| Insulet | May-26 | Insulet initiated a massive recall of approximately 7 million patch pumps following a serious leak risk linked to tubing tears. Associated with multiple serious adverse events, this second device recall within a year impacts competitive positioning and raises significant market concerns regarding the manufacturing quality and reliability of patch-based insulin delivery systems. |
| Diabeloop | May-26 | Diabeloop obtained CE Mark approval for its DBLG2 automated insulin delivery system, initiating a phased European rollout. The algorithm integrates Dexcom G7 continuous glucose monitoring with ViCentra's Kaleido and Dana-i insulin delivery platforms, expanding the market availability of AI-driven diabetes management solutions and strengthening interoperable device ecosystems. |
| Medtronic | Apr-25 | Medtronic advanced its collaboration with Abbott by submitting an interoperable insulin pump for FDA review. Designed to integrate directly with Abbott's continuous glucose monitoring ecosystem, the strategic submission accelerates the industry transition toward interoperable diabetes management frameworks and provides patients with expanded device combinations. |
| Sequel | Mar-24 | Sequel secured FDA clearance for its Twist Automated insulin delivery system, introducing the first platform capable of directly measuring volume with each delivered dose. By integrating with Tidepool Loop technology for automated adjustments via continuous glucose monitor readings, the launch brings enhanced dosing precision and automated loop capabilities to the market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Insulin Pumps Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Reimbursement Type | Public/Government Insurance, Private Insurance, Self-Pay |
| Distribution Channel | Direct Sales, Hospital & Institutional Procurement, Retail & Specialty Pharmacies, Online Channels |
| Patient Population | Type 1 Diabetes, Type 2 Diabetes, Pediatric Patients, Adult Patients |
Insulin Pumps Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Diabetes Care Transformation Analysis |
|
| Automated Insulin Delivery Adoption |
|
| Reimbursement and Access Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the insulin pumps market?
What is the anticipated CAGR of the insulin pumps industry?
How is integrated diabetes management reshaping adoption in the insulin pumps market?
What purchasing trends are driving demand for next-generation insulin pumps?
Why do hospitals remain the largest end-use segment in the insulin pumps market?
Which product segment is expanding fastest in the insulin pumps market?
Why is North America the largest insulin pumps market?
What is fueling Asia Pacific’s growth in insulin pumps?
Who are the major participants shaping the insulin pumps landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization